Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03133013 · ClinicalTrials.gov registry record · NA
Objective Evaluation of Depression Using Sleep EEG
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03133013: Completed NA study, sponsored by Stanford University.
NCT03133013 is a NA study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03133013, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to test the ability of a brainwave measurement device (SLEEPSCOPE) in identifying and assisting in the diagnosis of depression. The brainwave data from individuals with untreated depression and healthy participants will be collected and analyzed. The ability to obtain brainwave data from individuals in their homes while they're sleeping would represent a significant advance in depression research.
Interventions
- DEVICE SLEEPSCOPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03133013
The ClinicalTrials.gov registry entry for NCT03133013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SLEEPSCOPE is the first listed.
NCT03133013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03133013 about?
NCT03133013 is a clinical study titled "Objective Evaluation of Depression Using Sleep EEG". The purpose of this study is to test the ability of a brainwave measurement device (SLEEPSCOPE) in identifying and assisting in the diagnosis of depression. The brainwave data from individuals with untreated depression and healthy participants will be collected and analyzed. The ability to obtain br...
What is the current status of trial NCT03133013?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-05-01. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03133013?
The interventions under investigation include: SLEEPSCOPE (DEVICE).
Who is sponsoring clinical trial NCT03133013?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.